13F
← All fund report cards

Crescent Grove Advisors, LLC

13F equity value
$1.0B
Positions
300
Top 10 concentration
34.4%
Quarters / total new picks
32 / 391
13F equity value over time
$0M$533M$1B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 62.5% of quarters (excess t = 1.77, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+3.4%
t-stat
1.77
Quarterly win rate
63%
Annualized excess
+2.1%
$1 → follow vs universe
$2.42 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.99420180630: follow 1.08120180930: follow 1.15020181231: follow 1.17120190331: follow 1.20320190630: follow 1.09920190930: follow 1.18320191231: follow 0.97520200331: follow 1.18220200630: follow 1.23420200930: follow 1.37420201231: follow 1.46520210331: follow 1.54320210630: follow 1.60320210930: follow 1.48320211231: follow 1.27820220331: follow 1.29420220630: follow 1.24820220930: follow 1.28820221231: follow 1.26220230331: follow 1.43320230630: follow 1.44520230930: follow 1.58220231231: follow 1.64520240331: follow 1.58020240630: follow 1.72120240930: follow 1.71820241231: follow 1.68020250331: follow 1.96420250630: follow 2.11820250930: follow 2.62420251231: follow 2.422 0.84 1.84 2.83 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 300 · 2026 Q1

Ticker Value Weight QoQ
IVV $64M
6.3%
TRIM
ZWS $60M
5.9%
TRIM
VOO $50M
5.0%
HOLD
SPY $32M
3.1%
TRIM
VTI $28M
2.8%
HOLD
IEMG $26M
2.5%
ADD
IEF $24M
2.4%
ADD
QQQ $21M
2.1%
HOLD
IJR $21M
2.1%
HOLD
CDW $21M
2.1%
ADD
IJH $21M
2.1%
HOLD
ICE $20M
2.0%
TRIM
IEFA $19M
1.9%
HOLD
AAPL $19M
1.9%
HOLD
SGOV $18M
1.8%
TRIM
NATL $17M
1.7%
ADD
IWF $17M
1.7%
HOLD
FNF $17M
1.7%
HOLD
IUSV $17M
1.7%
HOLD
UYLD $13M
1.2%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.